Bempedoic Acid: for Whom and When.
Journal Information
Full Title: Curr Atheroscler Rep
Abbreviation: Curr Atheroscler Rep
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Vascular Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Conflict of InterestA.C. has received honoraria from Amgen, AstraZeneca, Daiichi Sankyo, Novartis, Recordati, Servier, and Sanofi and a grant from Daiichi Sankyo. M.R. received a grant from Daiichi Sankyo; M.B. speakers bureau: Amgen, Esperion, Herbapol, Kogen, KRKA, Novartis, Polpharma, Sanofi, Servier, Teva, Viatris, and Zentiva; consultant to Akcea, Amgen, Daichii Sankyo, Esperion, Freia Pharmaceuticals, Polfarmex, and Sanofi; and grants from Amgen, Viatris, Sanofi, and Valeant. S.C. has received payment or honoraria from Fidia, Techdow, and Bruno. C.R.S. has nothing to disclose. Human and Animal Rights and Informed ConsentThis article does not contain any studies with human or animal subjects performed by any of the authors. Conflict of Interest A.C. has received honoraria from Amgen, AstraZeneca, Daiichi Sankyo, Novartis, Recordati, Servier, and Sanofi and a grant from Daiichi Sankyo. M.R. received a grant from Daiichi Sankyo; M.B. speakers bureau: Amgen, Esperion, Herbapol, Kogen, KRKA, Novartis, Polpharma, Sanofi, Servier, Teva, Viatris, and Zentiva; consultant to Akcea, Amgen, Daichii Sankyo, Esperion, Freia Pharmaceuticals, Polfarmex, and Sanofi; and grants from Amgen, Viatris, Sanofi, and Valeant. S.C. has received payment or honoraria from Fidia, Techdow, and Bruno. C.R.S. has nothing to disclose."
"Funding Open access funding provided by Università degli Studi di Milano within the CRUI-CARE Agreement. MR received research funding by Banca di Credito Cooperativo di Milano (2022)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025